Amber Jaycocks

Learn More
BACKGROUND There is evidence to suggest that antiretroviral therapy (ART) and testing for human immunodeficiency virus (HIV) reduce the probability of transmission of HIV. This has led health officials across the United States to take steps toward a test-and-treat policy. However, the extent of the benefits generated by test-and-treat is debatable, and(More)
BACKGROUND Data on effectiveness of preexposure prophylaxis (PrEP) for human immunodeficiency virus (HIV)-uninfected women attempting conception with HIV-infected male partners are limited to observational studies. METHODS To explore the benefits of PrEP for conception, we developed a model to estimate the average annual probability of a woman remaining(More)
This document and trademark(s) contained herein are protected by law as indicated in a notice appearing later in this work. This electronic representation of RAND intellectual property is provided for non-commercial use only. Unauthorized posting of RAND electronic documents to a non-RAND website is prohibited. RAND electronic documents are protected under(More)
We thank Gonzalez-Serna and his colleagues for initiating a discussion on our paper that models the impact of the test-and-treat policy on the human immuno-deficiency virus (HIV) epidemic in Los Angeles County. Gonzalez-Serna et al contest the relevance of our findings that test-and-treat could potentially increase multidrug resistance (MDR) in Los Angeles(More)
  • 1